134 related articles for article (PubMed ID: 35025781)
41. Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer.
Bal CS; Kumar A; Pant GS
Nucl Med Commun; 2003 Feb; 24(2):203-8. PubMed ID: 12548045
[TBL] [Abstract][Full Text] [Related]
42. [Radioiodine in the treatment of generalized papillary and follicular thyroid carcinoma].
Mäenpää H
Duodecim; 2014; 130(6):573-9. PubMed ID: 24724456
[TBL] [Abstract][Full Text] [Related]
43. Pelvic radioiodine uptake in a rectal wall teratoma after thyroidectomy for papillary carcinoma.
Lakshmanan M; Reynolds JC; Del Vecchio S; Merino MJ; Norton JA; Robbins J
J Nucl Med; 1992 Oct; 33(10):1848-50. PubMed ID: 1403156
[TBL] [Abstract][Full Text] [Related]
44. Commentary: Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
Terris DJ
Head Neck; 2010 Jun; 32(6):698-9. PubMed ID: 20187017
[No Abstract] [Full Text] [Related]
45. An Unusual False-Positive Uptake of Radioiodine Caused by Posttraumatic Superficial Scab.
Xiao L; Jiang L; Huang R; Tian R; Liu B
Clin Nucl Med; 2022 Apr; 47(4):350-351. PubMed ID: 34739399
[TBL] [Abstract][Full Text] [Related]
46. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.
Taylor T; Specker B; Robbins J; Sperling M; Ho M; Ain K; Bigos ST; Brierley J; Cooper D; Haugen B; Hay I; Hertzberg V; Klein I; Klein H; Ladenson P; Nishiyama R; Ross D; Sherman S; Maxon HR
Ann Intern Med; 1998 Oct; 129(8):622-7. PubMed ID: 9786809
[TBL] [Abstract][Full Text] [Related]
47. Unexpected Retrosternal Goiter Interpreted as Hyperfunctioning Metastasis on the Posttherapeutic 131I SPECT/CT.
Hou LY; Luo QY; Qiu ZL
Clin Nucl Med; 2022 Mar; 47(3):258-259. PubMed ID: 34661561
[TBL] [Abstract][Full Text] [Related]
48. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study.
Koh JM; Kim ES; Ryu JS; Hong SJ; Kim WB; Shong YK
Clin Endocrinol (Oxf); 2003 Apr; 58(4):421-7. PubMed ID: 12641624
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
[TBL] [Abstract][Full Text] [Related]
50. [Ovarian endometriosis cyst with iodine 131 uptake : first case of false positive in the follow up for differentiated thyroid carcinoma].
Lungo M; Tenenbaum F; Chaumerliac P; Vons C; Mirat A; Beuzen F; Luton JP; Richard B
Ann Endocrinol (Paris); 2000 May; 61(2):147-50. PubMed ID: 10891665
[TBL] [Abstract][Full Text] [Related]
51. [Treatment for microcarcinoma of the thyroid. Clinical experience].
Conzo G; Esposito MG; Di Marzo M; Astarita G; Celsi S
Tumori; 2003; 89(4 Suppl):210-1. PubMed ID: 12903596
[TBL] [Abstract][Full Text] [Related]
52. Fractionated dosage of radioiodine for the ablation of low-risk differentiated thyroid cancer has no impact on survival.
Woliński K; Czepczyński R; Stangierski A; Trojanowski M; Rewaj-Łosyk M; Ziemnicka K; Bączyk M; Dyzmann-Sroka A; Ruchała M
Endokrynol Pol; 2018; 69(3):230-234. PubMed ID: 29504625
[TBL] [Abstract][Full Text] [Related]
53. Effectiveness of preoperative radioactive iodine (131I) therapy for locally advanced papillary thyroid cancer: a case report.
Shingu K; Kobayashi S; Yokoyama S; Shimizu T; Kasuga Y; Fujimori M; Ito K; Hama Y; Amano J
Thyroid; 1998 Dec; 8(12):1113-6. PubMed ID: 9920366
[TBL] [Abstract][Full Text] [Related]
54. Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma.
Thompson GB; Hay ID
World J Surg; 2004 Dec; 28(12):1187-98. PubMed ID: 15517490
[TBL] [Abstract][Full Text] [Related]
55. False positive uptake in post-treatment iodine-131 whole-body scans secondary to contamination.
Schlosser J; Paliou M; Bravo-Vera R; Sheikh A; Gouller A
Thyroid; 2007 Jan; 17(1):81-2. PubMed ID: 17274756
[No Abstract] [Full Text] [Related]
56. Thyroidectomy without Radioiodine in Low-Risk Thyroid Cancer.
Gulec SA; McGoron AJ
N Engl J Med; 2022 Jun; 386(22):2154-2155. PubMed ID: 35648716
[No Abstract] [Full Text] [Related]
57. Thyroidectomy without Radioiodine in Low-Risk Thyroid Cancer.
Greenspan BS
N Engl J Med; 2022 Jun; 386(22):2154. PubMed ID: 35648715
[No Abstract] [Full Text] [Related]
58. Thyroidectomy without Radioiodine in Low-Risk Thyroid Cancer.
Tulchinsky M
N Engl J Med; 2022 Jun; 386(22):2153-2154. PubMed ID: 35648714
[No Abstract] [Full Text] [Related]
59. Resection of thyroid cancer metastases to the sternum.
Yanagawa J; Abtin F; Lai CK; Yeh M; Britten CD; Martinez D; Crisera CA; Holmes EC; Lee JM
J Thorac Oncol; 2009 Aug; 4(8):1022-5. PubMed ID: 19633476
[TBL] [Abstract][Full Text] [Related]
60. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
